Atlas Trials

Systemic Anaplastic Large Cell Lymphoma

5 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Systemic Anaplastic Large Cell Lymphoma

RecordFirmDate
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma (NCT06561048)Corvus Pharmaceuticals, Inc.2024-10-02
Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma (NCT02729961)University of Washington2018-01-03
Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma (NCT02652715)Mayo Clinic2016-01-19
A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib (NCT02487316)Jun Zhu2015-07-01
A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer (NCT00585195)Pfizer2006-04-19

Track Systemic Anaplastic Large Cell Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.